Putin discusses Russia’s economy growth with ministersBusiness & Economy September 24, 2:38
Lavrov warns against partition of SyriaRussian Politics & Diplomacy September 23, 0:00
Lavrov calls to coordinate Russian, US military action in SyriaRussian Politics & Diplomacy September 22, 21:05
Lavrov blames Obama administration for souring Russia-US tiesRussian Politics & Diplomacy September 22, 20:41
Waging war on Korean Peninsula inadmissible, says LavrovRussian Politics & Diplomacy September 22, 20:36
Russian Northern Fleet completes drills in ArcticMilitary & Defense September 22, 18:01
OPEC and non-OPEC countries to continue talks on oil production cut dealBusiness & Economy September 22, 17:28
Russian pair figure skaters Kavaguti, Smirnov retire from sportSport September 22, 16:48
Record number of delegations register for St. Petersburg-hosted IPU AssemblyRussian Politics & Diplomacy September 22, 16:47
MOSCOW, July 12. /TASS/. The first batch of 1,000 Ebola vaccine doses developed at the Gamaleya Research Institute of Epidemiology and Microbiology was sent to the Republic of Guinea on Wednesday, a TASS correspondent reported.
"The first batch of the vaccine is one thousand doses, which means that one thousand people will be vaccinated," said Alexander Semikhin, head of the Biotechnological Products Department at the Gamaleya Institute.
The vaccine is aimed at preventing the fever caused by the Ebola virus. According to Semiklhin, after the vaccination, revaccination is needed in 21 days’ time.
According to the Russian Health Ministry, Russia’s Gam Evac Combi is the world’s first officially registered vaccine approved for clinical use for the prevention of hemorrhagic fever caused by the Ebola virus.
The presentation of the Russian vaccines (named Gam Evac and Gam Evac Combi) to the World Health Organization (WHO) took place in Geneva on February 15.
At a meeting between Russian Health Minister Veronika Skvortsova and WHO Director-General Margaret Chan, the two sides emphasized the importance of the Russian Ebola vaccine for the international community.
According to Skvortsova, the Russian vaccine has proved its effectiveness and has practically no side effects.
"One hundred percent of vaccinated people have a high antibody titer to the causative agent. We have been monitoring the vaccinated individuals for five months now, and this titer has remained high for five months. The blood serum of those vaccinated completely kills and neutralizes the virus in laboratory conditions," the minister explained.